Pharmstandard-Leksredstva will Upgrade Its Production Facilities


The modernisation of production facilities was discussed on 17 June at a meeting of the Executive Director of Pharmstandard JSC Viktor Kharitonin and the Governor of the Kursk Region Roman Starovoit.

Photo: Kursk Region Administration official website

Pharmstandard will allocate about a billion roubles for these purposes. Modernisation will help create additional jobs, increase productivity and expand the range of products by adding new medicines to the portfolio. Currently, the plant produces up to 600 million packages a year.

Photo: Kursk Region Administration official website

"Pharmstandard-Leksredstva makes a significant contribution to the development of the economy of the Region. Today, the Company takes 3rd place in the Region in terms of production volumes. We are interested in the further development of our enterprise. Therefore, after receiving the justifications, we will consider the possibility of providing the Company with the most favourable environment in accordance with the legislation of the Kursk Region," said Roman Starovoit, Head of the Region. The statement of the Governor is quoted by the Press Service of the Administration of the Kursk Region.

Also, the meeting participants talked about the re-equipment of the laboratory of the Kursk Oncological Dispensary. It will be used for the state Unified Centralised Service of Medical Analysis in the territory of the Kursk Region. A similar improvement of the laboratory diagnostic system has already taken place in several other Russian regions, including the Belgorod Region.

Viktor Kharitonin expressed his willingness to share experience in the field of centralisation of laboratories.

Photo: Kursk Region Administration official website

 "At the moment, we are centralising laboratory services in approximately 10 constituent entities of the Russian Federation, including the Moscow Region, Perm, Omsk, Dagestan and Chelyabinsk. These projects are implemented as part of a public-private partnership," said the Executive Director of Pharmstandard. "The situation in the Kursk Region has its own differences, since there is already a good laboratory on the basis of the oncology centre, which needs to be re-equipped. From this point of view, we are ready to share our experience."


Back Print out